DigiBx
Meet Jacqueline Hall
DigiBx is a MedTech company that is accelerating diagnosis and personalised cancer patient treatment with digital biopsy.
Founder:
Jacqueline Hall
Problem
We are establishing a testing service that will enable comprehensive diagnostic results to the oncologist within 48 hours, combining tissue pathology (IHC and morphology) and molecular pathology mutation profiling using novel Oxford Nanopore Technology sequencing. This service will serve fast-progressing cancer patients that are currently not served by slow (2-4 week) turnaround time. In future, we will expand it to multi-omic data including DNA methylation and RNA for improved results.
Solution
Cancer patients and their treating oncologists and pathologists deserve the delivery of high-quality, integrated and timely diagnostic results to best support treatment decisions and diagnosis. Every minute counts for fast-progressing patients.
Market
Oncologists and Pathologists
Contact
